Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 23, 2024
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
[ Tue, Apr 23rd 2024
] - WOPRAI
Mon, April 22, 2024
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
[ Mon, Apr 22nd 2024
] - WOPRAI
Leland Gershell Maintained (TARA) at Buy with Increased Target to $30 on, Apr 22nd, 2024
Leland Gershell of Oppenheimer, Maintained "Protara Therapeutics, Inc." (TARA) at Buy with Increased Target from $26 to $30 on, Apr 22nd, 2024.
Leland has made no other calls on TARA in the last 4 months.
There is 1 other peer that has a rating on TARA. Out of the 1 peers that are also analyzing TARA, 0 agree with Leland's Rating of Hold.
This is the rating of the analyst that currently disagrees with Leland
- Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $23 on, Monday, April 8th, 2024
